Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...
In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a ...
Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...
First for Women on MSN12d
MDs Share 5 Things To Know About Blood Sugar Monitors—Even if You Don't Have DiabetesThe latest trend in health and fitness tracking may sound familiar: wearing continuous glucose monitors (CGMs). Many people ...
Two over-the-counter CGMs are currently on the US market that could be used for this purpose, Dexcom’s Stelo and Abbott’s Lingo (Abbott’s Rio CGM is for those with non–insulin-treated T2D).
The new device would give Dexcom a CGM that can be worn for as long as competitor Abbott’s Freestyle Libre 3 Plus sensor. COO ...
(Nasdaq:BBNX) shares rose after hours today on fourth-quarter results that topped the consensus sales forecast.
Amsterdam played host to this year's edition of the International Conference on Advanced Technologies & Treatments for ...
In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Hold rating on Johnson & Johnson (JNJ – Research Report), ...
Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...
Insulet announces the commercial launch of Omnipod 5 AID system in Australia, with Dexcom G6 and G7 CGM sensor compatibility.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results